China Grand Pharmaceutical and Healthcare Holdings Ltd (0512.HK)
23 Feb 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|42||2008||Executive Chairman of the Board|
|52||2008||Chief Executive Officer, Executive Director|
|30||2008||Executive Deputy Chairman of the Board|
|47||2011||General Manager of Zhejiang Xianle|
- BRIEF-China Grand Pharmaceutical And Healthcare Gets Drug Clinical Trial Approval Document From China FDA For Products
- BRIEF-China Grand Pharmaceutical and Healthcare announces subscription of shares of Conavi Medical
- BRIEF-China Grand Pharmaceutical and Healthcare Holdings says to establish JV co
- BRIEF-China Grand Pharmaceutical And Healthcare says Travoprost eye drops gets new drug certificate
- BRIEF-China Grand Pharmaceutical and Healthcare unit enters acquisition agreement